Strateg Iq Financial Group, LLC Bristol Myers Squibb CO Transaction History

Strateg Iq Financial Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	SELL	$57.89 - $64.73 $868 - $970	-15 Reduced 0.37%	4,064 $235,000
Q1 2023 Apr 19, 2023	BUY	$65.71 - $74.53 $1,905 - $2,161	29 Added 0.72%	4,079 $282,000
Q3 2022 Oct 21, 2022	BUY	$0.13 - $76.84 $13 - $7,684	100 Added 2.53%	4,050 $288,000
Q1 2022 Apr 21, 2022	SELL	$61.48 - $73.72 $24,100 - $28,898	-392 Reduced 9.03%	3,950 $288,000
Q4 2021 Feb 04, 2022	BUY	$53.63 - $62.52 $232,861 - $271,461	4,342 New	4,342 $271,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Strateg Iq Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Strateg Iq Financial Group, LLC with notifications on news.